Condition
Calprotectin
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04973423Not ApplicableRecruiting
STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
NCT07524153Completed
Diode Laser and S100A8 in Peri-Implantitis
NCT04835727Not ApplicableCompleted
Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission
NCT03255564CompletedPrimary
Monitor Faecal Calprotectin Concentration in Infants With Heart Defects
NCT04491799Completed
Fecal Calprotectin Level in Patients With Nosocomial Diarrhea
NCT00577928CompletedPrimary
Value of Fecal Calprotectin
Showing all 6 trials